Alexander Hieu Nguyen - 22 Jan 2025 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role: CLO and Head of Ops
Signature: /s/ Alexander Hieu Nguyen
Issuer symbol: UBX
Transactions as of: 22 Jan 2025
Transactions value $: $0
Form type: 4
Date filed: 23 Jan 2025, 16:07
Previous filing: 06 Nov 2024
Next filing: 05 Feb 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UBX	Stock Option (Right to Buy)	Award	$0	+150K		$0.00	150K	22 Jan 2025	Common Stock	150K	$2.09	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The underlying shares vest and become exercisable pursuant to the following schedule: one third of the shares subject to the option vest on December 31, 2025 and the remaining shares subject to the option vest in 24 successive, equal monthly installments thereafter on each monthly anniversary of December 31, 2025 until fully vested on December 31, 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Content

The underlying shares vest and become exercisable pursuant to the following schedule: one third of the shares subject to the option vest on December 31, 2025 and the remaining shares subject to the option vest in 24 successive, equal monthly installments thereafter on each monthly anniversary of December 31, 2025 until fully vested on December 31, 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.